Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
12/2008
12/31/2008WO2009000775A1 Post-screening labeling of on-bead compounds
12/31/2008WO2008141097A3 Stereoisomers propofol therapeutic compounds
12/31/2008EP2008997A1 Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative
12/31/2008EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound
12/31/2008EP1040119B1 Hemiasterlin analogs
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/24/2008WO2008156817A2 Renin inhibitors
12/23/2008US7468440 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
12/23/2008CA2238427C Production method of aminobenzene compound
12/23/2008CA2212326C O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
12/18/2008WO2008151992A2 A novel process for the preparation of 3-amino-pentan-1,5-diol
12/18/2008WO2008151785A1 Method for producing a compound which has at least one ether group
12/18/2008WO2008151784A1 Method for hydrogenating glycerol
12/18/2008WO2008100977A3 Carbamates therapeutic release agents as amidase inhibitors
12/18/2008US20080312469 Preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
12/18/2008US20080312467 useful for the preparation of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)-propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidine-7-one, a MAP-kinase inhibitor useful in the treatment of rheumatoid arthritis; one pot process
12/18/2008US20080312403 Aromatic urethane acrylates having a high refractive index
12/18/2008US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders
12/18/2008US20080311635 Process for the preparation of (s)(+)-3-(aminomethyl)-5-methylhexanoic acid
12/18/2008DE102007027371A1 Verfahren zur Herstellung einer Verbindung aufweisend mindestens eine Ester-Gruppe A process for preparing a compound comprising at least one ester group
12/18/2008CA2690327A1 A novel process for the preparation of 3-amino-pentan-1,5-diol
12/17/2008EP1542968B1 Process for preparing intermediates
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008CN100443467C Substituted aromatic amide derivative intemediate thereof, agrohorticultral insecticide containing thereof and method for use thereof
12/11/2008WO2008148747A2 Pdz domain modulators
12/11/2008WO2008110308A3 Novel herbicides
12/11/2008US20080306147 Illudin Analogs Useful as Anticancer Agents
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008CA2591431A1 Novel process for the preparation of phenylcarbamates
12/10/2008EP1999107A2 Amine derivatives
12/10/2008EP1999106A1 A hydride reduction process for preparing quinolone intermediates
12/10/2008EP1856035B1 Process for preparaing protected amiidines
12/09/2008US7462650 Trifunctional photoinitiators
12/09/2008US7462630 Diarylalkene derivatives and novel diarylalkane derivatives
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/03/2008EP1996564A1 Dibenzyl amine compounds and derivatives
12/03/2008CN100439334C Process for preparing intermediates
12/03/2008CN100439320C Intermediates for preparation of arthropodicidal oxadiazines
12/02/2008US7459479 Benzylated PDE4 inhibitors
12/02/2008US7459472 Aryl and heteroaryl compounds, compositions, and methods of use
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
11/2008
11/27/2008WO2008144635A1 Method and composition for treating fibrous substrates
11/27/2008WO2008142100A1 Method for producing carbonate-terminated urethanes
11/27/2008US20080294289 Preparation and Use of Alkylating Agents
11/26/2008CN101312955A Process for producing optically active piperazine compound
11/26/2008CN101311164A Novel process for refining medicines
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456133 Substituted arylketones
11/20/2008WO2008141099A1 Therapeutic compounds
11/20/2008WO2008141097A2 Stereoisomers propofol therapeutic compounds
11/20/2008WO2008139467A2 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
11/20/2008WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008US20080287535 biphenyl-diazene oxide carboxylate compounds; pesticide; controlling undesirable pests by applying to plant foliage
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008CA2685813A1 Therapeutic compounds
11/20/2008CA2685570A1 Therapeutic compounds
11/19/2008EP1992611A1 Novel isodipeptide
11/19/2008EP1992605A1 Method of deuterizing benzyl-position in -o-benzyl group
11/19/2008EP1991524A1 A process for the preparation of phenylcarbamates
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/14/2008CA2631110A1 A process for the preparation of (s)(+)-3-(aminomethyl)-5-methylhexanoic acid
11/13/2008WO2008137165A1 Anti-glycated cd59 antibodies and uses thereof
11/13/2008WO2008135273A1 Urethane and oligourethane derivatives and corresponding uses and methods for producing water marks using the offset printing technique
11/13/2008US20080281095 Asparatyl protease inhibitor
11/12/2008CN101304966A Organic compounds
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449315 Bifunctional energy-reversible acyl-compositions
11/06/2008WO2008134326A1 Novel aldehyde composition
11/06/2008WO2008048373A3 Compounds and methods for modulating protein degradation
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
11/06/2008US20080274116 Lipids, Lipid Complexes and Use Thereof
11/05/2008EP1355876B1 Methods of chemical synthesis of phenolic nitrogen mustard prodrugs
11/05/2008CN100430376C Improved method for preparing N-methyl-3-phenyl-3-hydroxy-propylamine
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
10/2008
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008095841A3 Nitric oxide donor compounds
10/29/2008EP1562979B1 Tubulysins, method for producing the same and tubulysin preparations
10/28/2008US7442791 Aminoalkylamide substituted cyclohexyl derivatives
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/28/2008CA2152979C Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
10/23/2008WO2008125486A1 Process of deacetalisation of alpha aminoacetals
10/23/2008WO2008124969A1 Preparation method of rivastigmine and its intermediates
10/23/2008US20080262246 Novel chemical intermediates; reacting with organometallic compound
10/23/2008US20080262234 Reacting secondary amine, carbon dioxide, triarylsilyl chloride and halogenation agent
10/23/2008US20080261982 autoimmune disease and liver cirrhosis; useful for killing hyperproliferating cells
10/23/2008US20080261950 Drug hybrid of rivastigmine or physostigmine with tranylcypromine, amoxapine, desipramine, nortriptyline, protriptyline, fluoxetine, fluvoxamine, paroxetine, duloxetine, betahistine, amlodipine, proylhexedrine, rimantadine, desloratadine; Alzheimer's disease; Parkinson's disease, impairment in memory
10/23/2008CA2683612A1 Process of deacetalisation of alpha aminoacetals
10/22/2008EP1982985A2 Method for manufacturing a purine derivative
10/22/2008EP1148046B1 Process for the preparation of alpha-aminoketones
10/22/2008CN101291916A 9-aminocarbonylsubstituted derivatives of glycylcyclines
10/22/2008CN101289441A Method for synthesizing 5-methyl-5-propyl-1,3-dioxane-2-ketone and carisoprodol
10/21/2008US7439394 Cyclohexyl-1,4-diamine compounds
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439382 4-alkyl-2-haloaniline derivatives and process for producing the same
10/21/2008US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008US20080255231 Crystalline form of [3-[ alpha -(Dimethylamino)-ethyl]phenyl]-N-methylethylcarbamate hydrogentartrate
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 157